Literature DB >> 15287365

[Contrast agents in MRT. Substance, effects, pharmacology and validity].

P Reimer1, R Vosshenrich.   

Abstract

The use of intravenous contrast agents in magnetic resonance imaging (MRI) has become well established clinical practice. Contrast agents provide additional information in many applications. Gadolinium chelates constitute the largest group of MR contrast agents and are considered to be safe. Different groups of contrast agents are established for clinical application: low concentrated gadolinium chelates, high concentrated gadolinium chelates, superparamagnetic iron oxide particles and hepatobiliary contrast agents. The review discusses the clinical applications and the safety issues involved with administration of intravenous contrast agents in MR imaging. Several approaches of intravascular or blood pool agents are also presented.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287365     DOI: 10.1007/s00117-004-1026-8

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  50 in total

1.  Gadolinium-enhanced MR angiography: artifacts and pitfalls.

Authors:  V S Lee; D J Martin; G A Krinsky; N M Rofsky
Journal:  AJR Am J Roentgenol       Date:  2000-07       Impact factor: 3.959

2.  Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

Authors:  J Petersein; A Spinazzi; A Giovagnoni; P Soyer; F Terrier; R Lencioni; C Bartolozzi; L Grazioli; A Chiesa; R Manfredi; P Marano; E L Van Persijn Van Meerten; J L Bloem; C Petre; G Marchal; A Greco; M T McNamara; A Heuck; M Reiser; M Laniado; C Claussen; H E Daldrup; E Rummeny; M A Kirchin; G Pirovano; B Hamm
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

3.  Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers.

Authors:  A Spinazzi; V Lorusso; G Pirovano; M Kirchin
Journal:  Acad Radiol       Date:  1999-05       Impact factor: 3.173

4.  [Contrast-enhanced MR angiography of the arterial and portovenous system of the liver with varying concentrations of contrast medium].

Authors:  R Vosshenrich; B Engeroff; S Obenauer; E Grabbe
Journal:  Rofo       Date:  2003-09

Review 5.  Soluble-type hepatobiliary contrast agents for MR imaging.

Authors:  C de Haën; L Gozzini
Journal:  J Magn Reson Imaging       Date:  1993 Jan-Feb       Impact factor: 4.813

6.  Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits.

Authors:  Thomas Allkemper; Christoph Bremer; Lars Matuszewski; Wolfgang Ebert; Peter Reimer
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

7.  MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.

Authors:  S W Young; B B Simpson; A V Ratner; C Matkin; E A Carter
Journal:  Magn Reson Med       Date:  1989-04       Impact factor: 4.668

Review 8.  Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals.

Authors:  C de Haën; R La Ferla; F Maggioni
Journal:  J Comput Assist Tomogr       Date:  1999-11       Impact factor: 1.826

9.  Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.

Authors:  D H Carr; J Brown; G M Bydder; R E Steiner; H J Weinmann; U Speck; A S Hall; I R Young
Journal:  AJR Am J Roentgenol       Date:  1984-08       Impact factor: 3.959

10.  Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography.

Authors:  Annette Hentsch; Manuela A Aschauer; Jörn O Balzer; Joachim Brossmann; Hans P Busch; Kirsten Davis; Philippe Douek; Franz Ebner; Jos M A van Engelshoven; Michaela Gregor; Christian Kersting; Patrick R Knüsel; Edward Leen; Tim Leiner; Christian Loewe; Simon McPherson; Peter Reimer; Fritz K W Schäfer; Matthias Taupitz; Siegfried A Thurnher; Bernd Tombach; Robin Wegener; Dominik Weishaupt; James F M Meaney
Journal:  Eur Radiol       Date:  2003-03-25       Impact factor: 5.315

View more
  2 in total

1.  Erroneous intra-articular injection of gadolinium solution at 0.5 mol/l concentration: a case report.

Authors:  Eugenio A Genovese; Elena Bertolotti; Carlo Fugazzola
Journal:  Cases J       Date:  2009-12-14

2.  Estimation of the stable frozen zone volume and the extent of contrast for a therapeutic substance.

Authors:  Nikolai N Korpan; Sergey G Chefranov
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.